• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THORATEC CORPORATION HEARTMATE 3 LVAS IMPLANT KIT; VENTRICULAR (ASSIST) BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THORATEC CORPORATION HEARTMATE 3 LVAS IMPLANT KIT; VENTRICULAR (ASSIST) BYPASS Back to Search Results
Model Number 106524US
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Bacterial Infection (1735); Dehydration (1807); Unspecified Infection (1930); Nausea (1970); Weight Changes (2607); Skin Infection (4544)
Event Date 04/16/2022
Event Type  Injury  
Event Description
It was reported that the patient experienced lowered pulsatility index (pi) pressure with flow and power normal.Patient was recommended to increase fluid intake.Patient denies lightheadedness, shortness of breath, edema, or alarms.Mean arterial pressure (map) was normal throughout.A routine appointment and labs scheduled for (b)(6) 2022.On (b)(6) 2022, the patient was noted to have continually fluctuating pi with episodes of nausea.On (b)(6) 2022, the patient reported their left thoracotomy incision opening with drainage present.They were admitted to the hospital with iv antibiotics.Blood cultures came back positive for enterococcus faecalis.On (b)(6) 2022, picc line was placed for long term iv antibacterial therapy at home.A positron emission tomography (pet) scan was scheduled to determine if the implantable cardioverter-defibrillator (icd) is the cause of the infection.The scan will also determine if the pump is also infected.
 
Manufacturer Narrative
No further information was provided.A supplemental report will be submitted once the manufacturer¿s investigation is complete.
 
Event Description
On (b)(6) 2022 a positron emission tomography (pet) scan was performed and moderate uptake around the pump and outflow cannula was seen.New uptake was noted around the patient's driveline.Post surgical changes versus infection etiology were considered.An incision and drainage procedure was performed and a wound vac was placed on the patient's thoracotomy site.The patient's infection would be reassessed to see if an early transplant listing would be required.On (b)(6) 2022 the patient had a cardiothoracic surgery appointment and was noted to be improving with negative cultures and no signs of purulent drainage.On (b)(6) 2022 the patient's jp drain was removed.The patient's infection resolved without sequelae on (b)(6) 2022.The pi pressure drop the patient had experienced was due to hypovolemia.The left ventricular assist system (lvas) was operating as intended.The patient was stable and would be seen for routine follow ups.On (b)(6) 2022 it was reported that the patient gained (b)(4) with a map of (b)(4).The patient's losartan was decreased to 12.5 daily.No dizziness reported by the patient, diuretics were decreased and diet restrictions provided.
 
Manufacturer Narrative
Section a- date of birth: patient privacy laws prohibit the release of private patient information and the patient's date of birth should have been removed from the previous report.Manufacturer's investigation conclusion: a direct correlation between the reported events and the device could not be conclusively determined through this evaluation.The patient remains ongoing on heartmate 3 left ventricular assist system (lvas), serial number (b)(6).No product is available for investigation.The relevant sections of the device history records for (b)(6) were reviewed and showed no deviations from manufacturing or quality assurance specifications.The heartmate 3 lvas instructions for use (ifu) is currently available.Section 1, "introduction," lists infection as adverse event which may be associated with the use of heartmate 3 lvas.Section 6, "patient care and management," lists hypovolemia as a potential late postimplant complication.The heartmate 3 lvas patient handbook is also currently available.Both the ifu and patient handbook contain various sections regarding infection and how to prevent it.No further information was provided.The manufacturer is closing the file on this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HEARTMATE 3 LVAS IMPLANT KIT
Type of Device
VENTRICULAR (ASSIST) BYPASS
Manufacturer (Section D)
THORATEC CORPORATION
6035 stoneridge drive
pleasanton CA 94588
Manufacturer (Section G)
THORATEC CORPORATION
6035 stoneridge drive
pleasanton CA 94588
Manufacturer Contact
bob fryc
6035 stoneridge drive
pleasanton, CA 94588
7818528204
MDR Report Key14347525
MDR Text Key291317216
Report Number2916596-2022-10683
Device Sequence Number1
Product Code DSQ
UDI-Device Identifier00813024013297
UDI-Public00813024013297
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P160054
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study,Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 08/05/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date11/09/2023
Device Model Number106524US
Device Catalogue Number106524US
Device Lot Number8123474
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 04/22/2022
Initial Date FDA Received05/10/2022
Supplement Dates Manufacturer Received07/13/2022
Supplement Dates FDA Received08/05/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/03/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention; Life Threatening;
Patient Age42 YR
Patient SexFemale
Patient Weight82 KG
-
-